In a 61‑year‑old male with end‑stage renal disease (chronic kidney disease stage 5) on thrice‑weekly hemodialysis via a right internal‑jugular dialysis catheter who developed chills and a single episode of vomiting during a dialysis session, has leukocytosis, bilateral pleural effusions, new‑onset pneumonia, markedly elevated transaminases, severe hypokalemia, hypomagnesemia, hypophosphatemia, and combined respiratory alkalosis with metabolic acidosis, what is the appropriate empiric antimicrobial regimen and catheter management for a suspected catheter‑related bloodstream infection?

Management of Suspected Catheter-Related Bloodstream Infection in Hemodialysis Patient

Initiate empiric vancomycin plus gram-negative coverage immediately, obtain blood cultures from the catheter (since peripheral access is limited), and defer catheter removal until culture results and clinical response are assessed at 2–3 days. 1

Immediate Empiric Antimicrobial Therapy

Start vancomycin plus gram-negative coverage based on local antibiogram (third-generation cephalosporin, carbapenem, or β-lactam/β-lactamase combination). 1 Given the patient's new-onset pneumonia on chest X-ray and severe leukocytosis (WBC 16.48 with 97% neutrophils), broad gram-negative coverage is essential. 1

Specific Dosing Regimen for Hemodialysis Patients:

• Vancomycin: 20 mg/kg loading dose (approximately 1,200 mg for this 61-year-old male) infused during the last hour of the next dialysis session, then 500 mg during the last 30 minutes of each subsequent dialysis session 1
• Gentamicin (or tobramycin): 1 mg/kg, not to exceed 100 mg, administered after each dialysis session 1
• Alternative gram-negative coverage: Ceftazidime 1 g IV after each dialysis session 1

The guideline notes that cefazolin may substitute for vancomycin only in units with low methicillin-resistant staphylococcal prevalence, which is not established in this case. 1

Blood Culture Strategy

Obtain blood cultures from the dialysis catheter itself since peripheral venous access is often unavailable or should be preserved for future arteriovenous fistula creation in hemodialysis patients. 1 The IDSA guidelines specifically address this unique situation: when peripheral blood cannot be obtained, no other catheter is available, there is no drainage from the insertion site, and no alternate infection source is evident, positive catheter-drawn cultures should guide continuation of antimicrobial therapy. 1

Draw blood samples during the hemodialysis session from bloodlines connected to the central venous catheter. 1

Catheter Management Decision Algorithm

Do NOT Remove Catheter Immediately If:

The patient can be managed as an outpatient with empiric antibiotics, given he is currently hemodynamically stable (BP 150/90, no fever at presentation, alert and conversant). 1

Reassess at 48–72 Hours:

If symptoms resolve within 2–3 days (chills, vomiting) and blood cultures grow organisms OTHER than S. aureus, Pseudomonas species, or Candida species:

• Option 1: Exchange the infected catheter over a guidewire for a new long-term hemodialysis catheter 1
• Option 2: Retain the catheter and add antibiotic lock therapy as adjunctive treatment after each dialysis session for 10–14 days 1

If blood cultures grow S. aureus, Pseudomonas species, or Candida species:

• Immediately remove the catheter and insert a temporary (non-tunneled) catheter at another anatomical site 1
• If absolutely no alternative sites exist, exchange over a guidewire as a last resort 1
• Place a new long-term hemodialysis catheter only after obtaining negative blood cultures 1

If symptoms persist beyond 2–3 days OR evidence of metastatic infection develops:

• Remove the catheter regardless of organism 1

Critical Metabolic Derangements Requiring Urgent Correction

This patient has life-threatening electrolyte abnormalities that must be addressed concurrently:

• Severe hypokalemia (K 2.1 mEq/L): Requires aggressive IV potassium replacement to prevent cardiac arrhythmias 2
• Severe hypomagnesemia (Mg 0.61 mmol/L): Must be corrected as magnesium deficiency impairs potassium repletion 2
• Severe hypophosphatemia (Ph 0.83 mmol/L): Common in critically ill patients and requires careful repletion 2

These severe electrolyte disturbances may contribute to the patient's symptoms and complicate infection management. 2

Antibiotic Lock Therapy (If Catheter Retained)

If the decision is made to retain the catheter based on clinical response and organism identification, use antibiotic lock solutions after each dialysis session: 1

• Vancomycin lock: 2.5–5.0 mg/mL with 2,500–5,000 IU/mL heparin 1
• Ceftazidime lock: 0.5 mg/mL with 100 IU/mL heparin (for gram-negative organisms) 1
• Gentamicin lock: 1.0 mg/mL with 2,500 IU/mL heparin 1

Higher vancomycin concentrations (5 mg/mL) are more efficacious than 1 mg/mL for eradicating staphylococci embedded in biofilm. 1

Antibiotic De-escalation

If cultures grow methicillin-susceptible S. aureus, switch from vancomycin to cefazolin at 20 mg/kg (actual body weight), rounded to the nearest 500-mg increment, administered after each dialysis session. 1 This switch is critical as cefazolin demonstrates superior outcomes compared to vancomycin for methicillin-susceptible organisms. 1

Duration of Therapy

• Standard uncomplicated CRBSI: 2–3 weeks if catheter removed and symptoms resolve rapidly 1
• Persistent bacteremia >72 hours after catheter removal: 4–6 weeks 1
• Endocarditis or suppurative thrombophlebitis: 4–6 weeks 1
• Osteomyelitis: 6–8 weeks 1

Follow-Up Monitoring

Obtain surveillance blood cultures 1 week after completing the antibiotic course if the catheter was retained. 1 If these cultures are positive, remove the catheter and place a new long-term dialysis catheter only after obtaining negative blood cultures. 1

Common Pitfalls to Avoid

• Do not delay antibiotic initiation while awaiting culture results in a symptomatic hemodialysis patient with suspected CRBSI 1
• Do not use peripheral veins intended for future arteriovenous fistula creation for blood draws 1
• Do not automatically remove the catheter in all cases—this patient's stable presentation and lack of high-risk organisms (pending cultures) may allow catheter salvage 1
• Do not forget to address the severe electrolyte abnormalities (K 2.1, Mg 0.61, Ph 0.83) which pose immediate life-threatening risks 2
• Do not overlook the new-onset pneumonia seen on chest X-ray, which may represent a separate infection source or hematogenous seeding 1
• Do not use guidewire exchange if S. aureus, Pseudomonas, or Candida are isolated unless absolutely no alternative venous access sites exist 1

Additional Considerations for This Patient

The markedly elevated transaminases (AST 632, ALT 178) and combined respiratory alkalosis with metabolic acidosis suggest systemic illness beyond simple catheter infection. 1 The bilateral pleural effusions and new pneumonia may represent septic emboli or concurrent pulmonary infection requiring extended antimicrobial therapy. 1 The patient's severe anemia (Hgb 107 g/L) and iron overload (TSAT 113%) complicate management and may require transfusion if hemodynamic instability develops. 3, 4